

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | nuclear pore complex assembly (GO:0051292) | 6.43413381 |
| 2 | regulation of nucleobase-containing compound transport (GO:0032239) | 6.01341391 |
| 3 | negative thymic T cell selection (GO:0045060) | 5.68368303 |
| 4 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.59850557 |
| 5 | cell wall macromolecule metabolic process (GO:0044036) | 5.48869757 |
| 6 | nuclear pore organization (GO:0006999) | 5.47280698 |
| 7 | negative T cell selection (GO:0043383) | 5.35323422 |
| 8 | monoubiquitinated protein deubiquitination (GO:0035520) | 5.24920936 |
| 9 | cytoplasmic mRNA processing body assembly (GO:0033962) | 5.03047843 |
| 10 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 5.00792643 |
| 11 | regulation of RNA export from nucleus (GO:0046831) | 4.94408616 |
| 12 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.65564298 |
| 13 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 4.63447109 |
| 14 | production of molecular mediator involved in inflammatory response (GO:0002532) | 4.54849323 |
| 15 | positive regulation of viral genome replication (GO:0045070) | 4.50992990 |
| 16 | pore complex assembly (GO:0046931) | 4.48692772 |
| 17 | negative regulation of DNA repair (GO:0045738) | 4.40119978 |
| 18 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 4.38242471 |
| 19 | positive regulation of chemokine secretion (GO:0090197) | 4.33145798 |
| 20 | glucosamine-containing compound catabolic process (GO:1901072) | 4.12646209 |
| 21 | DNA duplex unwinding (GO:0032508) | 4.09369066 |
| 22 | histone mRNA catabolic process (GO:0071044) | 4.01852280 |
| 23 | histone-serine phosphorylation (GO:0035404) | 3.98037864 |
| 24 | cellular response to ethanol (GO:0071361) | 3.97744036 |
| 25 | regulation of translational fidelity (GO:0006450) | 3.96338249 |
| 26 | DNA geometric change (GO:0032392) | 3.92641228 |
| 27 | programmed necrotic cell death (GO:0097300) | 3.83293318 |
| 28 | necrotic cell death (GO:0070265) | 3.82203898 |
| 29 | regulation of gamma-delta T cell activation (GO:0046643) | 3.81430653 |
| 30 | cellular response to prostaglandin stimulus (GO:0071379) | 3.78700394 |
| 31 | N-terminal protein amino acid acetylation (GO:0006474) | 3.77723930 |
| 32 | regulation of chemokine secretion (GO:0090196) | 3.73884668 |
| 33 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.72809085 |
| 34 | viral mRNA export from host cell nucleus (GO:0046784) | 3.68782909 |
| 35 | regulation of centriole replication (GO:0046599) | 3.65927765 |
| 36 | ether lipid metabolic process (GO:0046485) | 3.61190592 |
| 37 | histone phosphorylation (GO:0016572) | 3.57292107 |
| 38 | protein K48-linked deubiquitination (GO:0071108) | 3.55097871 |
| 39 | thymic T cell selection (GO:0045061) | 3.51889578 |
| 40 | regulation of centrosome duplication (GO:0010824) | 3.50711889 |
| 41 | regulation of isotype switching to IgG isotypes (GO:0048302) | 3.46525537 |
| 42 | necroptotic process (GO:0070266) | 3.40170392 |
| 43 | regulation of NFAT protein import into nucleus (GO:0051532) | 3.39120749 |
| 44 | positive regulation of DNA-templated transcription, initiation (GO:2000144) | 3.38694343 |
| 45 | mitotic nuclear envelope disassembly (GO:0007077) | 3.36757309 |
| 46 | protein K63-linked deubiquitination (GO:0070536) | 3.34408670 |
| 47 | pericardium development (GO:0060039) | 3.33879220 |
| 48 | response to prostaglandin E (GO:0034695) | 3.31317563 |
| 49 | positive regulation of B cell differentiation (GO:0045579) | 3.31089510 |
| 50 | rRNA catabolic process (GO:0016075) | 3.25508773 |
| 51 | positive regulation of granulocyte differentiation (GO:0030854) | 3.23607769 |
| 52 | peptidyl-lysine trimethylation (GO:0018023) | 3.20624805 |
| 53 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 3.19170340 |
| 54 | nuclear envelope disassembly (GO:0051081) | 3.18098963 |
| 55 | membrane disassembly (GO:0030397) | 3.18098963 |
| 56 | replicative senescence (GO:0090399) | 3.17230038 |
| 57 | pre-miRNA processing (GO:0031054) | 3.16680600 |
| 58 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.15975216 |
| 59 | regulation of necroptotic process (GO:0060544) | 3.15835458 |
| 60 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 3.14138581 |
| 61 | histone H3-K4 trimethylation (GO:0080182) | 3.12095423 |
| 62 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 3.11585495 |
| 63 | positive regulation of developmental pigmentation (GO:0048087) | 3.10864622 |
| 64 | DNA strand renaturation (GO:0000733) | 3.10700212 |
| 65 | snRNA transcription (GO:0009301) | 3.10409949 |
| 66 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.03717535 |
| 67 | regulation of centrosome cycle (GO:0046605) | 3.01725303 |
| 68 | cytokine biosynthetic process (GO:0042089) | 3.01545617 |
| 69 | positive regulation of protein import into nucleus, translocation (GO:0033160) | 2.99137151 |
| 70 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 2.98920557 |
| 71 | intra-S DNA damage checkpoint (GO:0031573) | 2.98617354 |
| 72 | phospholipid translocation (GO:0045332) | 2.97535783 |
| 73 | lipid translocation (GO:0034204) | 2.97535783 |
| 74 | inner ear receptor cell differentiation (GO:0060113) | 2.94027341 |
| 75 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 2.93461252 |
| 76 | peptidyl-lysine dimethylation (GO:0018027) | 2.92683040 |
| 77 | positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261) | 2.89502885 |
| 78 | regulation of pigment cell differentiation (GO:0050932) | 2.89315412 |
| 79 | estrogen biosynthetic process (GO:0006703) | 2.88902429 |
| 80 | hair cell differentiation (GO:0035315) | 2.87848563 |
| 81 | nephron epithelium morphogenesis (GO:0072088) | 2.87641624 |
| 82 | nephron tubule morphogenesis (GO:0072078) | 2.87641624 |
| 83 | retinal cone cell development (GO:0046549) | 2.86358553 |
| 84 | base-excision repair, AP site formation (GO:0006285) | 2.85539350 |
| 85 | interkinetic nuclear migration (GO:0022027) | 2.83987262 |
| 86 | histone lysine methylation (GO:0034968) | 2.81104365 |
| 87 | T cell selection (GO:0045058) | 2.81023612 |
| 88 | positive regulation of transcription from RNA polymerase III promoter (GO:0045945) | 2.79857215 |
| 89 | regulation of protein polyubiquitination (GO:1902914) | 2.78740971 |
| 90 | histone H3-K9 methylation (GO:0051567) | 2.77599356 |
| 91 | regulation of energy homeostasis (GO:2000505) | 2.77158367 |
| 92 | meiotic chromosome segregation (GO:0045132) | 2.76910883 |
| 93 | nucleotide-excision repair, DNA damage removal (GO:0000718) | 2.76070683 |
| 94 | DNA excision (GO:0044349) | 2.76070683 |
| 95 | nuclear envelope organization (GO:0006998) | 2.75157192 |
| 96 | DNA conformation change (GO:0071103) | 2.72148526 |
| 97 | C4-dicarboxylate transport (GO:0015740) | 2.66343285 |
| 98 | N-terminal protein amino acid modification (GO:0031365) | 2.66017072 |
| 99 | cellular zinc ion homeostasis (GO:0006882) | 2.65864600 |
| 100 | positive regulation of cellular response to insulin stimulus (GO:1900078) | 2.65101487 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 6.25795305 |
| 2 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 4.57021274 |
| 3 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 4.32445616 |
| 4 | GATA1_22025678_ChIP-Seq_K562_Human | 4.30394366 |
| 5 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 3.68441955 |
| 6 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.65018404 |
| 7 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.26188174 |
| 8 | AR_21572438_ChIP-Seq_LNCaP_Human | 3.22683736 |
| 9 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.13623611 |
| 10 | IGF1R_20145208_ChIP-Seq_DFB_Human | 3.12435986 |
| 11 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.84465270 |
| 12 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 2.64448479 |
| 13 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 2.43501529 |
| 14 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 2.29624565 |
| 15 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 2.29075427 |
| 16 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.20938485 |
| 17 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 2.18265772 |
| 18 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.15394732 |
| 19 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.98985867 |
| 20 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.96188116 |
| 21 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.93171836 |
| 22 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.82699951 |
| 23 | PKCTHETA_26484144_Chip-Seq_BREAST_Human | 1.69515140 |
| 24 | MYB_26560356_Chip-Seq_TH2_Human | 1.58164677 |
| 25 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.54386219 |
| 26 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.54153158 |
| 27 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.50612706 |
| 28 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.49183926 |
| 29 | EWS_26573619_Chip-Seq_HEK293_Human | 1.48178157 |
| 30 | MYB_26560356_Chip-Seq_TH1_Human | 1.45981000 |
| 31 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.44389699 |
| 32 | FUS_26573619_Chip-Seq_HEK293_Human | 1.43560706 |
| 33 | TP53_16413492_ChIP-PET_HCT116_Human | 1.42916748 |
| 34 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.37311731 |
| 35 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.36599294 |
| 36 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.35791847 |
| 37 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.32270494 |
| 38 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.31878226 |
| 39 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.30407293 |
| 40 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.29817369 |
| 41 | STAT3_23295773_ChIP-Seq_U87_Human | 1.29614937 |
| 42 | GATA1_19941826_ChIP-Seq_K562_Human | 1.29060392 |
| 43 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.22642603 |
| 44 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.22463450 |
| 45 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.22423825 |
| 46 | MAF_26560356_Chip-Seq_TH1_Human | 1.20838762 |
| 47 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.20089578 |
| 48 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.20089578 |
| 49 | CEBPB_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.19763897 |
| 50 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.18490026 |
| 51 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.18326308 |
| 52 | FOXM1_26100407_CHIP-SEQ_Hek293_flp-in_Human | 1.18104356 |
| 53 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.17283463 |
| 54 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.13715188 |
| 55 | WDR5_24793694_ChIP-Seq_LNCAP_Human | 1.13605641 |
| 56 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.12884963 |
| 57 | TBX3_20139965_ChIP-Seq_ESCs_Mouse | 1.10100973 |
| 58 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.09766262 |
| 59 | TBX3_20139965_ChIP-Seq_MESCs_Mouse | 1.07777266 |
| 60 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.07474496 |
| 61 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.06484296 |
| 62 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.06065699 |
| 63 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.05601865 |
| 64 | GATA2_19941826_ChIP-Seq_K562_Human | 1.05083318 |
| 65 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.04982921 |
| 66 | TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 1.04209657 |
| 67 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.04043233 |
| 68 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.03339763 |
| 69 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.03087433 |
| 70 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.01817356 |
| 71 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.01540159 |
| 72 | MAF_26560356_Chip-Seq_TH2_Human | 1.00883157 |
| 73 | GATA2_21186366_ChIP-Seq_BM-HSCs_Mouse | 1.00834922 |
| 74 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.99709107 |
| 75 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.98692971 |
| 76 | TCF4_23295773_ChIP-Seq_U87_Human | 0.94312254 |
| 77 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.93677184 |
| 78 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.88676482 |
| 79 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.88559885 |
| 80 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.88559885 |
| 81 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.88295986 |
| 82 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.86254205 |
| 83 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 0.85371823 |
| 84 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.84994841 |
| 85 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.84914194 |
| 86 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.84344879 |
| 87 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.83735940 |
| 88 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.81069215 |
| 89 | ETV1_20927104_ChIP-Seq_GIST48_Human | 0.80375888 |
| 90 | VDR_23849224_ChIP-Seq_CD4+_Human | 0.80178024 |
| 91 | TBL1_22424771_ChIP-Seq_293T_Human | 0.79449188 |
| 92 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.79103853 |
| 93 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.78396887 |
| 94 | CHD1_26751641_Chip-Seq_LNCaP_Human | 0.78366338 |
| 95 | MYC_22102868_ChIP-Seq_BL_Human | 0.78302701 |
| 96 | * GATA3_26560356_Chip-Seq_TH2_Human | 0.78032727 |
| 97 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.76651293 |
| 98 | CBX2_22325352_ChIP-Seq_293T-Rex_Human | 0.76279839 |
| 99 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.76159999 |
| 100 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.75684571 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004145_abnormal_muscle_electrophysio | 5.16085691 |
| 2 | MP0008057_abnormal_DNA_replication | 4.75673322 |
| 3 | MP0003011_delayed_dark_adaptation | 3.60654686 |
| 4 | MP0003763_abnormal_thymus_physiology | 3.54149354 |
| 5 | MP0005174_abnormal_tail_pigmentation | 3.39283451 |
| 6 | MP0005171_absent_coat_pigmentation | 3.36858806 |
| 7 | MP0002009_preneoplasia | 3.25927556 |
| 8 | MP0004381_abnormal_hair_follicle | 3.19465697 |
| 9 | MP0000569_abnormal_digit_pigmentation | 3.12113219 |
| 10 | MP0003045_fibrosis | 2.42172190 |
| 11 | MP0010094_abnormal_chromosome_stability | 2.37740562 |
| 12 | MP0002277_abnormal_respiratory_mucosa | 2.23058634 |
| 13 | MP0002095_abnormal_skin_pigmentation | 2.19489996 |
| 14 | MP0003690_abnormal_glial_cell | 2.12252891 |
| 15 | MP0003646_muscle_fatigue | 2.07261642 |
| 16 | MP0004270_analgesia | 2.02928168 |
| 17 | MP0003136_yellow_coat_color | 2.02113501 |
| 18 | MP0003111_abnormal_nucleus_morphology | 1.97633294 |
| 19 | MP0010307_abnormal_tumor_latency | 1.88497807 |
| 20 | MP0000647_abnormal_sebaceous_gland | 1.80090852 |
| 21 | MP0005671_abnormal_response_to | 1.78238478 |
| 22 | MP0003191_abnormal_cellular_cholesterol | 1.76448856 |
| 23 | MP0005409_darkened_coat_color | 1.75137589 |
| 24 | MP0010352_gastrointestinal_tract_polyps | 1.70134682 |
| 25 | MP0001661_extended_life_span | 1.63460445 |
| 26 | MP0008961_abnormal_basal_metabolism | 1.59641962 |
| 27 | MP0002396_abnormal_hematopoietic_system | 1.57903556 |
| 28 | MP0002166_altered_tumor_susceptibility | 1.55743972 |
| 29 | MP0005423_abnormal_somatic_nervous | 1.54330438 |
| 30 | MP0000427_abnormal_hair_cycle | 1.52015547 |
| 31 | MP0003221_abnormal_cardiomyocyte_apopto | 1.51404558 |
| 32 | MP0005253_abnormal_eye_physiology | 1.47737968 |
| 33 | MP0001243_abnormal_dermal_layer | 1.45762301 |
| 34 | MP0001986_abnormal_taste_sensitivity | 1.44825978 |
| 35 | MP0004130_abnormal_muscle_cell | 1.41650108 |
| 36 | MP0003195_calcinosis | 1.33622732 |
| 37 | MP0000604_amyloidosis | 1.28275981 |
| 38 | MP0002168_other_aberrant_phenotype | 1.28274594 |
| 39 | MP0003077_abnormal_cell_cycle | 1.26434505 |
| 40 | MP0002019_abnormal_tumor_incidence | 1.26051110 |
| 41 | MP0004233_abnormal_muscle_weight | 1.24147551 |
| 42 | MP0008007_abnormal_cellular_replicative | 1.23602069 |
| 43 | MP0005551_abnormal_eye_electrophysiolog | 1.21255227 |
| 44 | MP0005647_abnormal_sex_gland | 1.20628049 |
| 45 | MP0002638_abnormal_pupillary_reflex | 1.16756491 |
| 46 | MP0000747_muscle_weakness | 1.13295924 |
| 47 | MP0000015_abnormal_ear_pigmentation | 1.12512795 |
| 48 | MP0003091_abnormal_cell_migration | 1.11210448 |
| 49 | MP0008995_early_reproductive_senescence | 1.03688835 |
| 50 | MP0002006_tumorigenesis | 1.02367968 |
| 51 | MP0000703_abnormal_thymus_morphology | 1.01392168 |
| 52 | MP0005076_abnormal_cell_differentiation | 0.99718969 |
| 53 | MP0003656_abnormal_erythrocyte_physiolo | 0.99658982 |
| 54 | MP0003890_abnormal_embryonic-extraembry | 0.99102228 |
| 55 | MP0003631_nervous_system_phenotype | 0.96304239 |
| 56 | MP0002075_abnormal_coat/hair_pigmentati | 0.96037473 |
| 57 | MP0004036_abnormal_muscle_relaxation | 0.94977741 |
| 58 | MP0004197_abnormal_fetal_growth/weight/ | 0.92682261 |
| 59 | MP0002088_abnormal_embryonic_growth/wei | 0.91612097 |
| 60 | MP0003633_abnormal_nervous_system | 0.90830777 |
| 61 | MP0005666_abnormal_adipose_tissue | 0.89058092 |
| 62 | MP0002398_abnormal_bone_marrow | 0.87387282 |
| 63 | MP0003632_abnormal_nervous_system | 0.87324518 |
| 64 | MP0005621_abnormal_cell_physiology | 0.86200712 |
| 65 | MP0003984_embryonic_growth_retardation | 0.86104749 |
| 66 | MP0005083_abnormal_biliary_tract | 0.85528946 |
| 67 | MP0000428_abnormal_craniofacial_morphol | 0.84818045 |
| 68 | MP0003448_altered_tumor_morphology | 0.84724965 |
| 69 | MP0004947_skin_inflammation | 0.84679234 |
| 70 | MP0002971_abnormal_brown_adipose | 0.81931342 |
| 71 | MP0002060_abnormal_skin_morphology | 0.81241418 |
| 72 | MP0003705_abnormal_hypodermis_morpholog | 0.78521217 |
| 73 | MP0008770_decreased_survivor_rate | 0.76671477 |
| 74 | MP0001191_abnormal_skin_condition | 0.75178226 |
| 75 | MP0004808_abnormal_hematopoietic_stem | 0.75021799 |
| 76 | MP0002086_abnormal_extraembryonic_tissu | 0.74421755 |
| 77 | MP0006054_spinal_hemorrhage | 0.71690938 |
| 78 | MP0004957_abnormal_blastocyst_morpholog | 0.69419547 |
| 79 | MP0002722_abnormal_immune_system | 0.68540355 |
| 80 | MP0000377_abnormal_hair_follicle | 0.67946228 |
| 81 | MP0005395_other_phenotype | 0.66100601 |
| 82 | MP0000689_abnormal_spleen_morphology | 0.66064924 |
| 83 | MP0001186_pigmentation_phenotype | 0.65850300 |
| 84 | MP0001672_abnormal_embryogenesis/_devel | 0.65679746 |
| 85 | MP0005380_embryogenesis_phenotype | 0.65679746 |
| 86 | MP0000350_abnormal_cell_proliferation | 0.63463668 |
| 87 | MP0001765_abnormal_ion_homeostasis | 0.63406358 |
| 88 | MP0005391_vision/eye_phenotype | 0.62247720 |
| 89 | MP0002269_muscular_atrophy | 0.61462705 |
| 90 | MP0000383_abnormal_hair_follicle | 0.60541179 |
| 91 | MP0003453_abnormal_keratinocyte_physiol | 0.59960710 |
| 92 | MP0003786_premature_aging | 0.59918960 |
| 93 | MP0005448_abnormal_energy_balance | 0.59229454 |
| 94 | MP0005410_abnormal_fertilization | 0.58967048 |
| 95 | MP0008058_abnormal_DNA_repair | 0.57873695 |
| 96 | MP0000538_abnormal_urinary_bladder | 0.57172119 |
| 97 | MP0000920_abnormal_myelination | 0.57019560 |
| 98 | MP0002177_abnormal_outer_ear | 0.56804661 |
| 99 | MP0000716_abnormal_immune_system | 0.56460066 |
| 100 | MP0001756_abnormal_urination | 0.56249605 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Global brain atrophy (HP:0002283) | 5.53455269 |
| 2 | Poikiloderma (HP:0001029) | 4.89089540 |
| 3 | Attenuation of retinal blood vessels (HP:0007843) | 4.78991400 |
| 4 | Chronic hepatic failure (HP:0100626) | 4.75035673 |
| 5 | Colitis (HP:0002583) | 4.21976233 |
| 6 | Type 2 muscle fiber atrophy (HP:0003554) | 4.19633708 |
| 7 | Entropion (HP:0000621) | 3.85281032 |
| 8 | Anhidrosis (HP:0000970) | 3.54028968 |
| 9 | Bony spicule pigmentary retinopathy (HP:0007737) | 3.50815515 |
| 10 | Periodontitis (HP:0000704) | 3.45765415 |
| 11 | Abnormality of DNA repair (HP:0003254) | 3.39284060 |
| 12 | Muscle fiber atrophy (HP:0100295) | 3.36704972 |
| 13 | Fatigable weakness (HP:0003473) | 3.34220040 |
| 14 | Abnormality of the neuromuscular junction (HP:0003398) | 3.34220040 |
| 15 | Short chin (HP:0000331) | 3.19215395 |
| 16 | Malignant hyperthermia (HP:0002047) | 3.16154640 |
| 17 | Basal cell carcinoma (HP:0002671) | 3.12390552 |
| 18 | Stomach cancer (HP:0012126) | 2.90922966 |
| 19 | Chorioretinal atrophy (HP:0000533) | 2.90200165 |
| 20 | Congenital sensorineural hearing impairment (HP:0008527) | 2.89088197 |
| 21 | T lymphocytopenia (HP:0005403) | 2.85817724 |
| 22 | Sandal gap (HP:0001852) | 2.81887057 |
| 23 | Colon cancer (HP:0003003) | 2.80026425 |
| 24 | Renovascular hypertension (HP:0100817) | 2.79266720 |
| 25 | Congenital stationary night blindness (HP:0007642) | 2.78760987 |
| 26 | Prominent nose (HP:0000448) | 2.68080509 |
| 27 | Squamous cell carcinoma (HP:0002860) | 2.61683620 |
| 28 | Easy fatigability (HP:0003388) | 2.61616970 |
| 29 | Hematochezia (HP:0002573) | 2.59861313 |
| 30 | Abnormality of T cell number (HP:0011839) | 2.55863480 |
| 31 | IgA deficiency (HP:0002720) | 2.51583980 |
| 32 | Inflammation of the large intestine (HP:0002037) | 2.51253523 |
| 33 | Submucous cleft hard palate (HP:0000176) | 2.49083121 |
| 34 | Truncal obesity (HP:0001956) | 2.46282477 |
| 35 | Abnormal pupillary function (HP:0007686) | 2.45807097 |
| 36 | Short humerus (HP:0005792) | 2.44698557 |
| 37 | Dysmetric saccades (HP:0000641) | 2.43882712 |
| 38 | Autoimmune hemolytic anemia (HP:0001890) | 2.32482363 |
| 39 | Gastrointestinal inflammation (HP:0004386) | 2.25042657 |
| 40 | IgM deficiency (HP:0002850) | 2.23081264 |
| 41 | Weak cry (HP:0001612) | 2.21843376 |
| 42 | Nephroblastoma (Wilms tumor) (HP:0002667) | 2.16589110 |
| 43 | Abnormality of the nasal septum (HP:0000419) | 2.15548048 |
| 44 | Hypoplasia of the pons (HP:0012110) | 2.14128475 |
| 45 | Abnormality of the intrinsic pathway (HP:0010989) | 2.11405496 |
| 46 | Abnormality of the hepatic vasculature (HP:0006707) | 2.09478439 |
| 47 | Hemorrhage of the eye (HP:0011885) | 2.08534171 |
| 48 | Chromsome breakage (HP:0040012) | 2.08103578 |
| 49 | Aplastic anemia (HP:0001915) | 2.07620860 |
| 50 | Decreased central vision (HP:0007663) | 2.07381773 |
| 51 | Abnormality of the fingertips (HP:0001211) | 2.07016936 |
| 52 | Obsessive-compulsive behavior (HP:0000722) | 2.06183943 |
| 53 | Aplasia/hypoplasia of the humerus (HP:0006507) | 2.06151979 |
| 54 | Cutaneous melanoma (HP:0012056) | 2.06035940 |
| 55 | Decreased lacrimation (HP:0000633) | 2.05096383 |
| 56 | Capillary hemangiomas (HP:0005306) | 2.03221634 |
| 57 | Embryonal renal neoplasm (HP:0011794) | 2.01229276 |
| 58 | Aplasia/Hypoplasia of the earlobes (HP:0009906) | 2.00570864 |
| 59 | Abnormal spermatogenesis (HP:0008669) | 2.00023948 |
| 60 | Papillary thyroid carcinoma (HP:0002895) | 2.00019839 |
| 61 | Abnormality of chromosome stability (HP:0003220) | 1.99831964 |
| 62 | Febrile seizures (HP:0002373) | 1.99596609 |
| 63 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 1.97512404 |
| 64 | Tubulointerstitial nephritis (HP:0001970) | 1.96914219 |
| 65 | Hypoplasia of the thymus (HP:0000778) | 1.96408563 |
| 66 | Alacrima (HP:0000522) | 1.89819522 |
| 67 | Abnormality of the pons (HP:0007361) | 1.88662432 |
| 68 | Flat cornea (HP:0007720) | 1.86072765 |
| 69 | Relative macrocephaly (HP:0004482) | 1.84727617 |
| 70 | Decreased muscle mass (HP:0003199) | 1.84691892 |
| 71 | Protruding tongue (HP:0010808) | 1.83147938 |
| 72 | Intestinal fistula (HP:0100819) | 1.79660579 |
| 73 | Acute hepatic failure (HP:0006554) | 1.78667635 |
| 74 | Depressed nasal tip (HP:0000437) | 1.78403637 |
| 75 | Pancreatic islet-cell hyperplasia (HP:0004510) | 1.75713403 |
| 76 | Villous atrophy (HP:0011473) | 1.75290819 |
| 77 | Abnormality of small intestinal villus morphology (HP:0011472) | 1.75290819 |
| 78 | Thrombocytosis (HP:0001894) | 1.75289374 |
| 79 | 11 pairs of ribs (HP:0000878) | 1.74572229 |
| 80 | Acute myeloid leukemia (HP:0004808) | 1.74202814 |
| 81 | Abnormality of alanine metabolism (HP:0010916) | 1.73843211 |
| 82 | Hyperalaninemia (HP:0003348) | 1.73843211 |
| 83 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.73843211 |
| 84 | Subacute progressive viral hepatitis (HP:0006572) | 1.73085012 |
| 85 | Aplasia/Hypoplasia involving the carpal bones (HP:0006502) | 1.71071682 |
| 86 | Ectropion (HP:0000656) | 1.70523216 |
| 87 | Partial agenesis of the corpus callosum (HP:0001338) | 1.70059270 |
| 88 | Prolonged partial thromboplastin time (HP:0003645) | 1.70009799 |
| 89 | Neonatal hypoglycemia (HP:0001998) | 1.67158706 |
| 90 | Acanthocytosis (HP:0001927) | 1.66667086 |
| 91 | Abnormality involving the epiphyses of the upper limbs (HP:0003839) | 1.65639439 |
| 92 | Viral hepatitis (HP:0006562) | 1.65401962 |
| 93 | Supernumerary spleens (HP:0009799) | 1.63483831 |
| 94 | Poikilocytosis (HP:0004447) | 1.62088782 |
| 95 | Abnormality of the columella (HP:0009929) | 1.61766947 |
| 96 | Overlapping toe (HP:0001845) | 1.61413477 |
| 97 | Azoospermia (HP:0000027) | 1.60057841 |
| 98 | Neoplasm of the liver (HP:0002896) | 1.59158391 |
| 99 | Portal hypertension (HP:0001409) | 1.59135068 |
| 100 | Birth length less than 3rd percentile (HP:0003561) | 1.58541699 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MUSK | 9.67130937 |
| 2 | TESK2 | 6.54296753 |
| 3 | RIPK1 | 4.83795999 |
| 4 | MAP3K10 | 3.08512240 |
| 5 | ACVR1B | 2.13960309 |
| 6 | TXK | 1.77577680 |
| 7 | IKBKE | 1.74589575 |
| 8 | BRD4 | 1.64236746 |
| 9 | BRSK2 | 1.63088474 |
| 10 | FRK | 1.61581429 |
| 11 | PDGFRB | 1.49521339 |
| 12 | CDK12 | 1.47676422 |
| 13 | CAMKK2 | 1.47406637 |
| 14 | NLK | 1.36865425 |
| 15 | AKT3 | 1.28683191 |
| 16 | ITK | 1.26254068 |
| 17 | BLK | 1.16874007 |
| 18 | TYK2 | 1.15998916 |
| 19 | TRIB3 | 1.14668769 |
| 20 | NEK6 | 1.13811336 |
| 21 | PASK | 1.08362439 |
| 22 | WNK1 | 0.99814744 |
| 23 | CAMKK1 | 0.99033281 |
| 24 | SGK2 | 0.98251746 |
| 25 | CDK8 | 0.92565232 |
| 26 | CAMK1D | 0.90839922 |
| 27 | PDK2 | 0.90752673 |
| 28 | ATR | 0.87155736 |
| 29 | JAK1 | 0.85878314 |
| 30 | LATS1 | 0.85420189 |
| 31 | MELK | 0.82065755 |
| 32 | ZAK | 0.78743860 |
| 33 | PRKCH | 0.78548102 |
| 34 | IRAK2 | 0.78159757 |
| 35 | WNK4 | 0.77078566 |
| 36 | SGK3 | 0.73778500 |
| 37 | PIK3CA | 0.72341871 |
| 38 | NEK9 | 0.72070649 |
| 39 | PDGFRA | 0.71709142 |
| 40 | TTK | 0.69999511 |
| 41 | TRPM7 | 0.69193019 |
| 42 | CAMK1G | 0.64845292 |
| 43 | EEF2K | 0.64724823 |
| 44 | FGFR3 | 0.64580135 |
| 45 | OBSCN | 0.64212522 |
| 46 | NTRK3 | 0.59529128 |
| 47 | CSK | 0.59374770 |
| 48 | CDC7 | 0.59109008 |
| 49 | JAK2 | 0.58863815 |
| 50 | SGK223 | 0.55951943 |
| 51 | SGK494 | 0.55951943 |
| 52 | TBK1 | 0.55044934 |
| 53 | MKNK2 | 0.54746414 |
| 54 | MARK2 | 0.53839354 |
| 55 | MTOR | 0.53298684 |
| 56 | TLK1 | 0.52121905 |
| 57 | IRAK4 | 0.51775167 |
| 58 | LCK | 0.51376149 |
| 59 | MAP3K7 | 0.50274350 |
| 60 | PIM1 | 0.50149706 |
| 61 | ATM | 0.49704773 |
| 62 | BMPR1B | 0.49455536 |
| 63 | BTK | 0.48588319 |
| 64 | TEC | 0.48432809 |
| 65 | ERBB2 | 0.48360669 |
| 66 | FGFR2 | 0.47307739 |
| 67 | STK38L | 0.45126953 |
| 68 | SGK1 | 0.43093684 |
| 69 | RIPK4 | 0.41308778 |
| 70 | PDK1 | 0.40394930 |
| 71 | RAF1 | 0.40386408 |
| 72 | CHEK2 | 0.39713018 |
| 73 | TYRO3 | 0.39502379 |
| 74 | MAPK11 | 0.39052363 |
| 75 | ZAP70 | 0.38055135 |
| 76 | RPS6KB2 | 0.37843362 |
| 77 | MAP2K6 | 0.37468558 |
| 78 | IRAK1 | 0.37058804 |
| 79 | MKNK1 | 0.36559045 |
| 80 | SYK | 0.36373850 |
| 81 | PRKAA2 | 0.36342312 |
| 82 | DYRK1B | 0.35135284 |
| 83 | MAP3K2 | 0.34687136 |
| 84 | CDK6 | 0.34652547 |
| 85 | ALK | 0.34241169 |
| 86 | ICK | 0.33975223 |
| 87 | MAP3K13 | 0.33612349 |
| 88 | MAPK15 | 0.32459860 |
| 89 | STK3 | 0.31934043 |
| 90 | CHEK1 | 0.29104666 |
| 91 | STK24 | 0.28098071 |
| 92 | RPS6KB1 | 0.25584731 |
| 93 | EPHA4 | 0.24736897 |
| 94 | TAF1 | 0.24322221 |
| 95 | CDC42BPA | 0.24205678 |
| 96 | CDK1 | 0.24022029 |
| 97 | MST1R | 0.23637614 |
| 98 | PDPK1 | 0.23557729 |
| 99 | FGFR1 | 0.22318685 |
| 100 | MAPK8 | 0.21781713 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.21678642 |
| 2 | Lysine degradation_Homo sapiens_hsa00310 | 2.21555962 |
| 3 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.17768026 |
| 4 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 2.14309655 |
| 5 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 2.06573737 |
| 6 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 2.02610216 |
| 7 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.81058289 |
| 8 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.75032884 |
| 9 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.72152426 |
| 10 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.69407084 |
| 11 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 1.68076256 |
| 12 | Cell cycle_Homo sapiens_hsa04110 | 1.67010440 |
| 13 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.61215521 |
| 14 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.59846030 |
| 15 | ABC transporters_Homo sapiens_hsa02010 | 1.57394517 |
| 16 | Basal transcription factors_Homo sapiens_hsa03022 | 1.55994226 |
| 17 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 1.48702537 |
| 18 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.45948326 |
| 19 | Thyroid cancer_Homo sapiens_hsa05216 | 1.43701073 |
| 20 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.41270743 |
| 21 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.32409448 |
| 22 | Platelet activation_Homo sapiens_hsa04611 | 1.32262383 |
| 23 | Measles_Homo sapiens_hsa05162 | 1.31775938 |
| 24 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 1.28811352 |
| 25 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.28412524 |
| 26 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 1.28331031 |
| 27 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.26977404 |
| 28 | Alcoholism_Homo sapiens_hsa05034 | 1.22848857 |
| 29 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 1.22325808 |
| 30 | FoxO signaling pathway_Homo sapiens_hsa04068 | 1.22261761 |
| 31 | Viral carcinogenesis_Homo sapiens_hsa05203 | 1.20759411 |
| 32 | RNA degradation_Homo sapiens_hsa03018 | 1.17252242 |
| 33 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.12561512 |
| 34 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.10338245 |
| 35 | Endometrial cancer_Homo sapiens_hsa05213 | 1.09477987 |
| 36 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.08626065 |
| 37 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.06980193 |
| 38 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.06237822 |
| 39 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.99896012 |
| 40 | RNA transport_Homo sapiens_hsa03013 | 0.98385504 |
| 41 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.98383668 |
| 42 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.98166405 |
| 43 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.97884487 |
| 44 | Homologous recombination_Homo sapiens_hsa03440 | 0.96849278 |
| 45 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.96547793 |
| 46 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.95921060 |
| 47 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.94590332 |
| 48 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.93890560 |
| 49 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.93844002 |
| 50 | Circadian rhythm_Homo sapiens_hsa04710 | 0.93459059 |
| 51 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.92525206 |
| 52 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.92328294 |
| 53 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.88471400 |
| 54 | Renin secretion_Homo sapiens_hsa04924 | 0.88376242 |
| 55 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.87984670 |
| 56 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.87359726 |
| 57 | Hepatitis C_Homo sapiens_hsa05160 | 0.86519457 |
| 58 | * Taste transduction_Homo sapiens_hsa04742 | 0.86500178 |
| 59 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.86294266 |
| 60 | Prostate cancer_Homo sapiens_hsa05215 | 0.85382651 |
| 61 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.83278129 |
| 62 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.82378737 |
| 63 | Glioma_Homo sapiens_hsa05214 | 0.82313482 |
| 64 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.81491353 |
| 65 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.79827733 |
| 66 | Olfactory transduction_Homo sapiens_hsa04740 | 0.78064927 |
| 67 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.77056674 |
| 68 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.76703226 |
| 69 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.74512417 |
| 70 | Colorectal cancer_Homo sapiens_hsa05210 | 0.73843200 |
| 71 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.73492994 |
| 72 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.72775767 |
| 73 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.71044944 |
| 74 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.70022446 |
| 75 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.68864841 |
| 76 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.67781321 |
| 77 | Pathways in cancer_Homo sapiens_hsa05200 | 0.67757759 |
| 78 | Adherens junction_Homo sapiens_hsa04520 | 0.67606808 |
| 79 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.65063560 |
| 80 | HTLV-I infection_Homo sapiens_hsa05166 | 0.64752253 |
| 81 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.63580831 |
| 82 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.61590077 |
| 83 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.59990086 |
| 84 | Hepatitis B_Homo sapiens_hsa05161 | 0.58148987 |
| 85 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.57203328 |
| 86 | Malaria_Homo sapiens_hsa05144 | 0.56748387 |
| 87 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.56661655 |
| 88 | Focal adhesion_Homo sapiens_hsa04510 | 0.56449273 |
| 89 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.56088690 |
| 90 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.55663799 |
| 91 | Nicotine addiction_Homo sapiens_hsa05033 | 0.55317701 |
| 92 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.54811812 |
| 93 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.53604162 |
| 94 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.52491085 |
| 95 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.51863357 |
| 96 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.51808555 |
| 97 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.51646408 |
| 98 | Insulin resistance_Homo sapiens_hsa04931 | 0.49794238 |
| 99 | Apoptosis_Homo sapiens_hsa04210 | 0.47788505 |
| 100 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.46961209 |

